Background: Various surgical modalities and transplantation techniques had been evolved for the treatment of recalcitrant stable vitiligo. Each of these techniques has its own limitations and side effects. There are insufficient studies evaluating the efficacy of transplantation of hair follicle (HF) units as a surgical modality for vitiligo treatment in comparison with the classic mini-punch grafting.Objectives: To compare the efficacy and safety of follicular unit transplantation (FUT) with mini-punch grafting (mPG) in cases of resistant and stable vitiligo.Methods: Twenty-five patients with stable vitiligo were included. Treated areas were classified into 2 groups: group I: Areas were treated with the FUT technique and group II: Areas were treated with mPG technique. Treated areas were exposed to narrowband ultraviolet B phototherapy for 6 months. After 3 months, follow-up patients' response was evaluated clinically and by dermoscopy.Results: Both techniques showed efficacy in repigmentation of stable vitiligo. Group II showed a statistically significant higher percentage of repigmentation and significant earlier repigmentation than group I. Cobblestone-like appearance was the major complication in group II, while no serious side effect was reported in group I. Leukotrichia was present in 8 patients, and 6 of them showed hair repigmentation evidently in group I.
Conclusion:Both techniques are effective, safe, and inexpensive methods of surgical repigmentation of stable localized/segmental vitiligo. mPG gives earlier and better percent of repigmentation, with higher incidence of cobblestoning. FUT is a good alternative for mPG, especially in hairy areas with better cosmetic outcome and minimal complications.
BackgroundYKL‐40 is a 40 kDa chitinase‐like glycoprotein that is predicted to contribute to the pathogenesis of several inflammatory and neoplastic conditions.ObjectivesTo assess YKL‐40 immunoexpression in different stages of mycosis fungoides (MF) to find out if YKL‐40 is playing a possible role in disease pathophysiology and progression.MethodsThis work included 50 patients with different stages of MF diagnosed on the basis of clinical, histopathological, and both CD4 and CD8 immunophenotyping, in addition to 25 normal control skin. The Immune Reactive Score (IRS) of YKL‐40 expression was determined in all specimens and statistically analyzed.ResultsYKL‐40 expression reported a significant rise in MF lesions compared to control skin. Among MF specimens, the mildest expression was observed in the early patch stage followed by the plaque stage, while the strongest was in tumor stages. Positive correlations were discovered between IRS of YKL‐40 expression in MF specimens and patients' age, disease chronicity, clinical staging, and TNMB classification.ConclusionYKL‐40 might participate in MF pathophysiology, and the highest expression is associated with advanced stages of the disease and poor outcomes. Therefore, it might be of value as a prognosticator for monitoring high‐risk MF patients and follow‐up assessment of treatment success.
YKL-40 is a glycoprotein that is formed by several types of cells that include immune, tumor, and stromal cells, and has growth factors and cytokines properties. Its exact function is not yet completely clear. It had been found markedly increased in the serum of individuals with various cutaneous and systemic inflammatory diseases suggesting a possible role in their development. Additionally, the degree of severity of the disease coincided with the blood levels of this protein. It may thus be regarded as one of the most useful indicators to assess the level and severity of inflammation in different disorders. Additionally, YKL-40 was found to be expressed by tumor-associated macrophages and several cancer cell types. Several study's findings indicated a substantial connection between YKL-40 and the development and propagation of cancer. As a result, it was thought that YKL-40 might be useful as a marker for the development of cancer and the patient's reaction to the applied drugs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.